Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
French National Agency for Research on AIDS and Viral Hepatitis |
---|---|
Information provided by: | French National Agency for Research on AIDS and Viral Hepatitis |
ClinicalTrials.gov Identifier: | NCT00122525 |
Observational studies suggest that male circumcision may provide protection against HIV-1 infection. A randomized, controlled, intervention trial was conducted in a general population of South Africa to test this hypothesis.
Condition | Intervention | Phase |
---|---|---|
HIV Infections Herpes Genitalis Venereal Diseases |
Procedure: Male Circumcision |
Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study |
Official Title: | Effect of Safe Male Circumcision on Incidence of Infection by HIV, HSV-2 and of Genital Ulceration |
Enrollment: | 3274 |
Study Start Date: | July 2002 |
Study Completion Date: | July 2005 |
This study is a randomized controlled intervention trial. This multi-centre study will take place in 3 centers located around Johannesburg, in the areas of Orange Farm, Sebokeng and Evaton. The intervention group patients (circumcised at the beginning of the trial) and the control group (uncircumcised men) will be followed during 21 months (from M.0 to M. 21). Randomization and medicalized circumcision will be performed at M.0 in the intervention group and might be optional in the control group at end of study. The medicalized circumcision effectiveness will be evaluated on and after M.3 (3 months after medicalized circumcision). Incidences (of HIV, HSV-2 infections and genital ulcer disease) will be compared from M.3 to M.21 between the intervention group and the control group. An intermediate analysis will take place at M. 12.
Ages Eligible for Study: | 18 Years to 24 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
South Africa, Johannesburg | |
MC Centre | |
Orange Farm, Johannesburg, South Africa |
Study Chair: | Bertran Auvert, MD | Hôpital Ambroise-Paré (AP-HP); Inserm U687 |
Principal Investigator: | Adrian Puren | NICD, Johannesburg, South Africa |
Study ID Numbers: | ANRS 1265 |
Study First Received: | July 19, 2005 |
Last Updated: | December 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00122525 |
Health Authority: | South Africa: National Health Research Ethics Council |
HIV Male circumcision Prevention |
HSV-2 Africa Sexual behavior |
Herpes Simplex Sexually Transmitted Diseases, Viral Herpes Genitalis Ulcer Acquired Immunodeficiency Syndrome Genital Diseases, Male Immunologic Deficiency Syndromes |
Herpesviridae Infections Genital Diseases, Female Virus Diseases HIV Infections Sexually Transmitted Diseases DNA Virus Infections Retroviridae Infections |
Communicable Diseases RNA Virus Infections Slow Virus Diseases |
Immune System Diseases Lentivirus Infections Infection |